288 related articles for article (PubMed ID: 36893895)
21. Ferroptosis: A flexible constellation of related biochemical mechanisms.
Dixon SJ; Pratt DA
Mol Cell; 2023 Apr; 83(7):1030-1042. PubMed ID: 36977413
[TBL] [Abstract][Full Text] [Related]
22. Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition.
Yi R; Wang H; Deng C; Wang X; Yao L; Niu W; Fei M; Zhaba W
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32452511
[TBL] [Abstract][Full Text] [Related]
23. Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration.
Hambright WS; Fonseca RS; Chen L; Na R; Ran Q
Redox Biol; 2017 Aug; 12():8-17. PubMed ID: 28212525
[TBL] [Abstract][Full Text] [Related]
24. HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells.
Luo Z; Zheng Q; Ye S; Li Y; Chen J; Fan C; Chen J; Lei Y; Liao Q; Xi Y
Cell Death Dis; 2024 Mar; 15(3):220. PubMed ID: 38493165
[TBL] [Abstract][Full Text] [Related]
25. Depletion of the N
Deng L; Di Y; Chen C; Xia J; Lei B; Li N; Zhang Q
Cell Death Dis; 2024 Mar; 15(3):181. PubMed ID: 38429265
[TBL] [Abstract][Full Text] [Related]
26. CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione/GPX4.
Chen S; Fan J; Xie P; Ahn J; Fernandez M; Billingham LK; Miska J; Wu JD; Wainwright DA; Fang D; Sosman JA; Wan Y; Zhang Y; Chandel NS; Zhang B
J Clin Invest; 2024 Mar; 134(8):. PubMed ID: 38441967
[TBL] [Abstract][Full Text] [Related]
27. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay.
Zhang H; Chen N; Ding C; Zhang H; Liu D; Liu S
Front Oncol; 2024; 14():1344290. PubMed ID: 38469234
[TBL] [Abstract][Full Text] [Related]
28. Ferroptosis in liver cancer: a key role of post-translational modifications.
Xu Y; Xing Z; Abdalla Ibrahim Suliman R; Liu Z; Tang F
Front Immunol; 2024; 15():1375589. PubMed ID: 38650929
[TBL] [Abstract][Full Text] [Related]
29. Progress in Understanding Ferroptosis and Challenges in Its Targeting for Therapeutic Benefit.
Zou Y; Schreiber SL
Cell Chem Biol; 2020 Apr; 27(4):463-471. PubMed ID: 32302583
[TBL] [Abstract][Full Text] [Related]
30. ML162 derivatives incorporating a naphthoquinone unit as ferroptosis/apoptosis inducers: Design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation.
Ma F; Li Y; Cai M; Yang W; Wu Z; Dong J; Qin JJ
Eur J Med Chem; 2024 Apr; 270():116387. PubMed ID: 38593589
[TBL] [Abstract][Full Text] [Related]
31. GPX4 overexpression does not alter atherosclerotic plaque development in ApoE knock-out mice.
Coornaert I; Breynaert A; Hermans N; De Meyer GR; Martinet W
Vasc Biol; 2024 May; ():. PubMed ID: 38717303
[TBL] [Abstract][Full Text] [Related]
32. Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy.
Yang N; Pan X; Zhou X; Liu Z; Yang J; Zhang J; Jia Z; Shen Q
Adv Healthc Mater; 2024 Mar; 13(7):e2302752. PubMed ID: 37975280
[TBL] [Abstract][Full Text] [Related]
33. Ferroptosis-modulating small molecules for targeting drug-resistant cancer: Challenges and opportunities in manipulating redox signaling.
Koeberle SC; Kipp AP; Stuppner H; Koeberle A
Med Res Rev; 2023 May; 43(3):614-682. PubMed ID: 36658724
[TBL] [Abstract][Full Text] [Related]
34. Caspase-2 protects against ferroptotic cell death.
Dawar S; Benitez MC; Lim Y; Dite TA; Yousef JM; Thio N; Garciaz S; Jackson TD; Milne JV; Dagley LF; Phillips WA; Kumar S; Clemons NJ
Cell Death Dis; 2024 Mar; 15(3):182. PubMed ID: 38429264
[TBL] [Abstract][Full Text] [Related]
35. Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.
Zhang X; Li X
Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050181
[TBL] [Abstract][Full Text] [Related]
36. DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma.
Li Q; Yuan H; Zhao G; Ou D; Zhang J; Li L; Li S; Feng T; Gu R; Kou Q; Wang Q; Li S; Wang G; Zhao M; Yu H; Qu J; Lin P; Li K
Biochem Pharmacol; 2024 May; 225():116251. PubMed ID: 38701867
[TBL] [Abstract][Full Text] [Related]
37. Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer.
DeAngelo SL; Dziechciarz S; Solanki S; Shin M; Zhao L; Balia A; El-Derany MO; Das NK; Castillo C; Bell HN; Paulo JA; Zhang Y; Rossiter NJ; McCulla EC; He J; Talukder I; Schafer ZT; Neamati N; Mancias JD; Koutmos M; Shah YM
bioRxiv; 2024 Apr; ():. PubMed ID: 38617233
[TBL] [Abstract][Full Text] [Related]
38. Transformable Supramolecular Self-Assembled Peptides for Cascade Self-Enhanced Ferroptosis Primed Cancer Immunotherapy.
Wang H; Jiao D; Feng D; Liu Q; Huang Y; Hou J; Ding D; Zhang W
Adv Mater; 2024 May; 36(21):e2311733. PubMed ID: 38339920
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.
Akiyama H; Zhao R; Ostermann LB; Li Z; Tcheng M; Yazdani SJ; Moayed A; Pryor ML; Slngh S; Baran N; Ayoub E; Nishida Y; Mak PY; Ruvolo VR; Carter BZ; Schimmer AD; Andreeff M; Ishizawa J
Leukemia; 2024 Apr; 38(4):729-740. PubMed ID: 38148395
[TBL] [Abstract][Full Text] [Related]
40. Ferroptosis: mechanisms, biology and role in disease.
Jiang X; Stockwell BR; Conrad M
Nat Rev Mol Cell Biol; 2021 Apr; 22(4):266-282. PubMed ID: 33495651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
